MarketPulse

clinical study

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Precipio Posts 30% Revenue Growth; Partners with Memorial Sloan-Kettering on Cancer Test

Cancer diagnostics firm $PRPO reports $24M in 2025 revenues, up 30% year-over-year, and publishes peer-reviewed study on its BCR::ABL1 blood test.
PRPOQ4 2025 earningsrevenue growth
BenzingaBenzinga··Prnewswire

IceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery